MAPK8 and cancer: In terms of upstream effectors, regulating kinases such as JNK in cancers that have been observed to have perturbed activity in various cancer tissue, especially the invasive triple negative MDA-MB-231 breast cancer cells, are targets for many exploratory research groups for shutting down cell cycle progression (Sur and Agrawal, 2016; Martino et al., 2019).